8/16/2019 Immunological Off-target Effects of Imatinib
1/16
http://dx.doi.org/10.1038/nrclinonc.2016.41mailto:[email protected]:[email protected]:[email protected]
8/16/2019 Immunological Off-target Effects of Imatinib
2/16
8/16/2019 Immunological Off-target Effects of Imatinib
3/16
8/16/2019 Immunological Off-target Effects of Imatinib
4/16
8/16/2019 Immunological Off-target Effects of Imatinib
5/16
8/16/2019 Immunological Off-target Effects of Imatinib
6/16
8/16/2019 Immunological Off-target Effects of Imatinib
7/16
8/16/2019 Immunological Off-target Effects of Imatinib
8/16
8/16/2019 Immunological Off-target Effects of Imatinib
9/16
8/16/2019 Immunological Off-target Effects of Imatinib
10/16
8/16/2019 Immunological Off-target Effects of Imatinib
11/16
8/16/2019 Immunological Off-target Effects of Imatinib
12/16
8/16/2019 Immunological Off-target Effects of Imatinib
13/16
8/16/2019 Immunological Off-target Effects of Imatinib
14/16
8/16/2019 Immunological Off-target Effects of Imatinib
15/16
https://clinicaltrials.gov/ct2/show/NCT01738139https://clinicaltrials.gov/ct2/show/NCT01738139https://clinicaltrials.gov/ct2/show/NCT01643278https://clinicaltrials.gov/ct2/show/NCT01643278https://clinicaltrials.gov/ct2/show/NCT02011945https://clinicaltrials.gov/ct2/show/NCT02011945
8/16/2019 Immunological Off-target Effects of Imatinib
16/16
